Table 4.
αB crystallin expression in renal cell carcinoma according to clinicopathologic characteristics
| αB crystallin | αB crystallin | 95% confidence interval | P value | |||
|---|---|---|---|---|---|---|
|
|
||||||
| Positive | Negative | Lower | Upper | |||
| Age | Mean | 57.80357 | 56.65714 | -6.762666 | 4.469809 | 0.686 |
| Sex | Male | 32 (52%) | 29 (48%) | 0.0816431 | 0.8321968 | 0.0125 |
| Female | 24 (80%) | 6 (20%) | ||||
| T stage | 1a | 24 (77%) | 7 (23%) | 0.04431 | ||
| 1b | 21 (60%) | 14 (40%) | ||||
| 2a | 4 (67%) | 2 (33%) | ||||
| 2b | 2 (67%) | 1 (33%) | ||||
| 3a | 4 (29%) | 10 (71%) | ||||
| 3b | 0 (NA) | 0 (NA) | ||||
| 3c | 0 (NA) | 0 (NA) | ||||
| 4 | 1 (50%) | 1 (50%) | ||||
| N stage | 0 | 55 (62%) | 34 (38%) | 0.02002464 | 129.11977469 | 1 |
| 1 | 1 (50%) | 1 (50%) | ||||
| Type | Clear cell | 52 (68%) | 25 (32%) | 1.426e-05 | ||
| Papillary | 4 (100%) | 0 (0%) | ||||
| Chromophobe | 0 (0%) | 10 (100%) | ||||
| Overall survival (days) | Mean | 1837.661 | 1818.257 | -514.4767 | 475.6696 | 0.9381 |